Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Surgery Today|February 2, 2019
Life-threatening complications after pulmonary resection for lung cancer in patients on chronic hemodialysisKenji Tomizawa, Katsuaki Sato, Shuta Ohara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 25, 2018
[A Case of Resected Superior Sulcus Tumor with Pathological Complete Response after Trimodality Therapy]Masaya Nishino, Kenji Tomizawa, Syuta Ohara, et al.
Surgery Today|February 21, 2021
The prevalence and risk factors associated with preoperative deep venous thrombosis in lung cancer surgeryToshiki Takemoto, Junichi Soh, Shuta Ohara, et al.
Lung Cancer (Amsterdam, Netherlands)|December 19, 2016
Prognostic impact of pleural lavage cytology in patients with primary lung cancerKenji Tomizawa, Masaya Nishino, Yuichi Sesumi, et al.
Translational Lung Cancer Research|November 19, 2020
Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot studyShuta Ohara, Kenichi Suda, Kazuko Sakai, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Clinical significance of tumor cavitation in surgically resected early-stage primary lung cancerKenji Tomizawa, Shigeki Shimizu, Shuta Ohara, et al.
Surgery Today|May 16, 2020
Prognostic value of plasma fibrinogen and D-dimer levels in patients with surgically resected non-small cell lung cancerShuta Ohara, Kenichi Suda, Kenji Tomizawa, et al.
Molecular Cancer Therapeutics|December 4, 2016
Characterization of EGFR T790M, L792F, and C797S Mutations as Mechanisms of Acquired Resistance to Afatinib in Lung CancerYoshihisa Kobayashi, Koichi Azuma, Hiroki Nagai, et al.
Cancer Science|February 5, 2016
Oncogene swap as a novel mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor in lung cancerHiroshi Mizuuchi, Kenichi Suda, Isao Murakami, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2015
EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIsYoshihisa Kobayashi, Yosuke Togashi, Yasushi Yatabe, et al.
Pageof 4